Rigel Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
166.44 M |
Public Float |
104.73 M |
Rigel Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.39 |
Market Cap |
$428.01 M |
Shares Outstanding |
167.19 M |
Public Float |
159.59 M |
Address |
1180 Veterans Boulevard South San Francisco California 94080 United States |
Employees | - |
Website | http://www.rigel.com |
Updated | 07/08/2019 |
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. It focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. |